Skip to main navigation
Loading
  • News
  • Investors
  • Careers
  • Contact
  • About Us
    • Our Mission & Vision
    • The Zevra Story
    • Leadership
    • Board of Directors
  • Our Approach
    • What We Do
    • Partnering
  • Patients & Providers
    • Niemann-Pick Disease Type C
    • Sleep Disorders
    • Expanded Access Policy
  • Science & Pipeline
    • Pipeline
    • Clinical Trials
    • Products
    • Publications & Presentations
  • Investors
    • Investor Relations
    • Events & Presentations
    • Stock Information
    • Press Releases
    • Corporate Governance
    • SEC Filings
    • Contact
    • Email Alerts
  • Careers
    • Culture
    • Job Openings
  • Contact
    • info@zevra.com
    • 888.958.1253
    • Facebook
    • Twitter
    • LinkedIn
  • Home
  • Menu Menu

SEC Filings

  • Overview
  • Events & Presentations
  • Stock Information
    • Stock Quote & Chart
    • Historic Stock Lookup
    • Analyst Coverage
  • Press Releases
  • Corporate Governance
    • Leadership
    • Board of Directors
    • Committee Composition
    • IRS – Required Disclosures
  • SEC Filings
    • Quarterly Results
  • Contact
  • Email Alerts
Filing date Form Description Filing Group View
03-06-2023 PRER14A

Proxy soliciting materials. Revised preliminary material

Proxy Filings
0001437749-23-005540.rtf
0001437749-23-005540.xls
0001437749-23-005540.pdf
View HTML
03-03-2023 PREN14A

Non-management preliminary proxy statements not involving contested solicitations

Proxy Filings
0001477932-23-001306.rtf
0001477932-23-001306.xls
0001477932-23-001306.pdf
View HTML
03-03-2023 DFAN14A

Additional proxy soliciting materials filed by non-management

Proxy Filings
0001477932-23-001311.rtf
0001477932-23-001311.xls
0001477932-23-001311.pdf
View HTML
02-27-2023 PREC14A

Preliminary proxy statement containing contested solicitations

Proxy Filings
0001437749-23-004742.rtf
0001437749-23-004742.xls
0001437749-23-004742.pdf
View HTML
02-27-2023 8-K

Report of unscheduled material events or corporate event

Current Reports
0001437749-23-004784.rtf
0001437749-23-004784.xls
0001437749-23-004784.pdf
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
02-27-2023 DEFA14A

Additional proxy soliciting materials - definitive

Proxy Filings
0001437749-23-004793.rtf
0001437749-23-004793.xls
0001437749-23-004793.pdf
View HTML
02-24-2023 8-K

Report of unscheduled material events or corporate event

Current Reports
0001437749-23-004450.rtf
0001437749-23-004450.xls
0001437749-23-004450.pdf
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
01-25-2023 8-K

Report of unscheduled material events or corporate event

Current Reports
0001437749-23-001701.rtf
0001437749-23-001701.xls
0001437749-23-001701.pdf
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
01-20-2023 8-K

Report of unscheduled material events or corporate event

Current Reports
0001437749-23-001447.rtf
0001437749-23-001447.xls
0001437749-23-001447.pdf
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
01-13-2023 4

Statement of changes in beneficial ownership of securities

3,4,5
0001437749-23-001059.rtf
0001437749-23-001059.xls
0001437749-23-001059.pdf
View HTML
Pagination
  • First page «
  • Previous page ‹
  • Page 1
  • Page 2
  • Current page 3
  • Page 4
  • Page 5
  • …
  • Next page ›
  • Last page »

Data provided by Kaleidoscope.

  • About Us
    • Our Mission & Vision
    • The Zevra Story
    • Leadership
    • Board of Directors
  • Our Approach
    • What We Do
    • Partnering
  • Patients & Providers
    • Niemann-Pick Disease Type C
    • Sleep Disorders
    • Expanded Access Policy
  • Science & Pipeline
    • Pipeline
    • Clinical Trials
    • Products
    • Publications & Presentations
  • Investors
    • Investor Relations
    • Events & Presentations
    • Stock Information
    • Press Releases
    • Corporate Governance
    • SEC Filings
    • Contact
    • Email Alerts
  • Careers
    • Culture
    • Job Openings
  • Contact
    • info@zevra.com
    • 888.958.1253
    • Facebook
    • Twitter
    • LinkedIn
  • Home

© 2023 Zevra Therapeutics, Inc. All rights reserved. Privacy Policy | Terms of Use

Scroll to top